Seeking Alpha

Codexis (CDXS) +8.5% premarket after announcing the FDA approved a new process it co-developed...

Codexis (CDXS) +8.5% premarket after announcing the FDA approved a new process it co-developed for manufacturing sitagliptin, the active pharmaceutical ingredient in Merck's (MRK) Januvia diabetes drug.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|